12D miR HR13_24
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Trp63
|
ENSMUSG00000022510.8 | transformation related protein 63 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Trp63 | mm10_v2_chr16_+_25801907_25801928 | 0.42 | 1.9e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr17_+_29090969 | 1.04 |
ENSMUST00000119901.1
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A (P21) |
chr7_-_141443314 | 0.70 |
ENSMUST00000106005.2
|
Lrdd
|
leucine-rich and death domain containing |
chr6_+_34709610 | 0.58 |
ENSMUST00000031775.6
|
Cald1
|
caldesmon 1 |
chr6_+_34709442 | 0.51 |
ENSMUST00000115021.1
|
Cald1
|
caldesmon 1 |
chr8_-_31918203 | 0.48 |
ENSMUST00000073884.4
|
Nrg1
|
neuregulin 1 |
chr3_-_108402589 | 0.45 |
ENSMUST00000147565.1
|
Celsr2
|
cadherin, EGF LAG seven-pass G-type receptor 2 (flamingo homolog, Drosophila) |
chr8_+_84686300 | 0.41 |
ENSMUST00000177531.1
|
Trmt1
|
tRNA methyltransferase 1 |
chr10_-_80671976 | 0.37 |
ENSMUST00000003433.6
|
Mknk2
|
MAP kinase-interacting serine/threonine kinase 2 |
chr1_-_9700209 | 0.36 |
ENSMUST00000088658.4
|
Mybl1
|
myeloblastosis oncogene-like 1 |
chr19_-_5875210 | 0.35 |
ENSMUST00000155227.1
|
Frmd8
|
FERM domain containing 8 |
chr7_-_116038734 | 0.34 |
ENSMUST00000166877.1
|
Sox6
|
SRY-box containing gene 6 |
chr8_+_85432686 | 0.29 |
ENSMUST00000180883.1
|
1700051O22Rik
|
RIKEN cDNA 1700051O22 Gene |
chr7_-_126160992 | 0.26 |
ENSMUST00000164741.1
|
Xpo6
|
exportin 6 |
chrX_-_150812932 | 0.26 |
ENSMUST00000131241.1
ENSMUST00000147152.1 ENSMUST00000143843.1 |
Maged2
|
melanoma antigen, family D, 2 |
chr2_+_25054396 | 0.25 |
ENSMUST00000102931.4
ENSMUST00000074422.7 ENSMUST00000132172.1 ENSMUST00000114388.1 ENSMUST00000114386.1 |
Nsmf
|
NMDA receptor synaptonuclear signaling and neuronal migration factor |
chrX_-_150812715 | 0.21 |
ENSMUST00000112697.3
|
Maged2
|
melanoma antigen, family D, 2 |
chr12_-_108003594 | 0.20 |
ENSMUST00000066060.4
|
Bcl11b
|
B cell leukemia/lymphoma 11B |
chr5_-_5265224 | 0.19 |
ENSMUST00000115450.1
|
Cdk14
|
cyclin-dependent kinase 14 |
chr10_-_61452658 | 0.18 |
ENSMUST00000167087.1
ENSMUST00000020288.7 |
Eif4ebp2
|
eukaryotic translation initiation factor 4E binding protein 2 |
chr2_-_12301914 | 0.15 |
ENSMUST00000028106.4
|
Itga8
|
integrin alpha 8 |
chr11_-_69948145 | 0.14 |
ENSMUST00000179298.1
ENSMUST00000018710.6 ENSMUST00000135437.1 ENSMUST00000141837.2 ENSMUST00000142500.1 |
Slc2a4
|
solute carrier family 2 (facilitated glucose transporter), member 4 |
chr5_+_142401484 | 0.13 |
ENSMUST00000072837.5
|
Foxk1
|
forkhead box K1 |
chr4_-_96591555 | 0.12 |
ENSMUST00000055693.8
|
Cyp2j9
|
cytochrome P450, family 2, subfamily j, polypeptide 9 |
chr8_+_27085520 | 0.12 |
ENSMUST00000178514.1
ENSMUST00000033876.7 |
Gpr124
|
G protein-coupled receptor 124 |
chr8_-_85432841 | 0.10 |
ENSMUST00000047749.5
|
4921524J17Rik
|
RIKEN cDNA 4921524J17 gene |
chr8_-_47352348 | 0.10 |
ENSMUST00000110367.2
|
Stox2
|
storkhead box 2 |
chr12_-_108003414 | 0.09 |
ENSMUST00000109887.1
ENSMUST00000109891.2 |
Bcl11b
|
B cell leukemia/lymphoma 11B |
chr11_-_95699143 | 0.09 |
ENSMUST00000062249.2
|
Gm9796
|
predicted gene 9796 |
chr8_+_27085835 | 0.09 |
ENSMUST00000165366.2
|
Gpr124
|
G protein-coupled receptor 124 |
chr4_+_43493345 | 0.09 |
ENSMUST00000030181.5
ENSMUST00000107922.2 |
Ccdc107
|
coiled-coil domain containing 107 |
chr19_-_6080311 | 0.09 |
ENSMUST00000159832.1
|
Vps51
|
vacuolar protein sorting 51 homolog (S. cerevisiae) |
chr13_-_55021287 | 0.08 |
ENSMUST00000148221.1
ENSMUST00000052949.6 |
Hk3
|
hexokinase 3 |
chrX_+_98149666 | 0.06 |
ENSMUST00000052837.7
|
Ar
|
androgen receptor |
chr15_+_76696725 | 0.05 |
ENSMUST00000023203.4
|
Gpt
|
glutamic pyruvic transaminase, soluble |
chrX_+_136822781 | 0.05 |
ENSMUST00000113085.1
|
Plp1
|
proteolipid protein (myelin) 1 |
chr19_-_5875268 | 0.04 |
ENSMUST00000025728.6
|
Frmd8
|
FERM domain containing 8 |
chr5_-_5266038 | 0.04 |
ENSMUST00000115451.1
ENSMUST00000115452.1 ENSMUST00000131392.1 |
Cdk14
|
cyclin-dependent kinase 14 |
chr1_+_180893107 | 0.04 |
ENSMUST00000085797.5
|
Lefty2
|
left-right determination factor 2 |
chrX_+_136822671 | 0.03 |
ENSMUST00000033800.6
|
Plp1
|
proteolipid protein (myelin) 1 |
chr16_-_23930787 | 0.02 |
ENSMUST00000061030.8
|
Rtp2
|
receptor transporter protein 2 |
chr16_+_37868383 | 0.02 |
ENSMUST00000078717.6
|
Lrrc58
|
leucine rich repeat containing 58 |
chr2_-_170427828 | 0.01 |
ENSMUST00000013667.2
ENSMUST00000109152.2 ENSMUST00000068137.4 |
Bcas1
|
breast carcinoma amplified sequence 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.1 | 1.0 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 0.3 | GO:0097534 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
0.1 | 0.4 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.5 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.1 | 0.5 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 0.3 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
0.0 | 0.2 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.0 | 0.3 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.0 | 0.4 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.1 | GO:0060599 | lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) positive regulation of epithelial cell proliferation involved in prostate gland development(GO:0060769) |
0.0 | 1.1 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.0 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.1 | 1.1 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.2 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.0 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.5 | GO:0030673 | axolemma(GO:0030673) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.0 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.1 | 0.5 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.4 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.0 | 0.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.0 | 0.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.0 | 0.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 1.0 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 1.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |